Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

Abstract

This preliminary evidence suggests that D-cycloserine may improve negative symptoms and cognitive deficits over a narrow dose range when added to conventional antipsychotic agents.